Encore: Male Birth Control Startup Gets $7 Million
Business Wars Daily
00:00
NetSuite: The Number One Cloud Financial System for Your Business
Your choice therapeutics, which makes a daily pill, wrapped up a $15 million funding round in July. For decades, anyone with a uterus has had to bear most of the burden when it comes to family planning. If these companies have their way, the narrative that birth control is only for women will certainly shift.
Transcript
Play full episode
